News

PharmaBlock Sciences recently announced the appointment of Dr. Shijie Zhang as Chief Technology Officer. Shijie joins the company from Agios Pharmaceuticals, Inc., where he was Director…
Read More...

Seattle Genetics announced that its collaborator, Takeda Pharmaceutical Company Limited (Takeda), has received approval from the Japanese Ministry of Health, Labour and Welfare for…
Read More...

BIA Separations announced the expansion of its services with the opening of a new upstream processing (USP) laboratory. The investment in the new facility comes in response to…
Read More...

Neurimmune announced the achievement of a key preclinical milestone in the ongoing collaboration with Ono Pharmaceutical Co., Ltd. In November 2017, the parties entered into a…
Read More...

Lonza announces the addition of two new Ibex Solutions offerings to Lonza's 100,000 m2 (1.1 million ft2) biopark in Visp (CH). In July 2017 Ibex Dedicate, a modular, technology-agnostic…
Read More...

Thermo Fisher Scientific announced its intent to open multiple Global Customer Solution Centers. The new Global Customer Solution Centers will focus on meeting and exceeding the demands…
Read More...

Emergex Vaccines Holding Limited announces that it has signed a Memorandum of Understanding (MoU) with Brazil-based Oswaldo Cruz Foundation ‘Fiocruz’ for the development of viral…
Read More...

Cardurion Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug Application (IND) for CRD-733, a Phosphodiesterase-9…
Read More...

Aphena Pharma Solutions Inc. has expanded its DEA operations and storage in both its Maryland and Tennessee manufacturing locations. Aphena's liquid and semisolids division in Easton,…
Read More...

BeiGene, Ltd., a commercial-stage biotechnology company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer,…
Read More...

Zosano Pharma Corporation announced the release of three registration batches of M207, the Company’s lead development candidate. The registration batches will be used to support…
Read More...

Molecular Templates announced an agreement with Takeda Pharmaceutical Company Limited (Takeda) for the joint development of CD38-targeted engineered toxin bodies (ETBs) for the…
Read More...

Abzena has signed an antibody humanisation agreement with Tmunity Therapeutics (Tmunity), a clinical stage T cell therapy company and a leader in the development of new Chimeric Antigen…
Read More...

Propanc Biopharma announced the execution of a research collaboration agreement with the University of Jaén, Spain, for the provision of research services and scientific technical…
Read More...

Adverum Biotechnologies announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for ADVM-022. ADVM-022 is a novel gene therapy candidate for the…
Read More...

AstraZeneca announced results from the BORA Phase III extension trial evaluating the long-term safety and efficacy of Fasenra (benralizumab) as an add-on maintenance treatment in…
Read More...

Just Biotherapeutics and Pandion Therapeutics announced that they have entered into an agreement for the development and cGMP clinical manufacturing by Just of Pandion’s lead program.…
Read More...

Valeo Pharma and Besins Healthcare announced a strategic agreement to commercialize Utrogestan (micronised natural progesterone; 200mg vaginal capsules) in Canada. Utrogestan is…
Read More...

Atomwise Inc. has entered into an evaluation agreement with Pfizer. Pfizer will evaluate Atomwise’s platform to identify potential drug candidates for up to three target proteins…
Read More...

Roivant Sciences announced the launch of Respivant Sciences, a biopharmaceutical company focused on improving the lives of patients suffering from serious respiratory diseases.…
Read More...